Astrea Bioseparations Expands Capacity for Chromatography Solutions in North America

Astrea Bioseparations (“Astrea Bio”), a leading provider of high-quality bioseparation and purification technologies that help to improve patie...

September 19, 2023 | Tuesday | News
Evaxion Expands Bacterial Vaccine Pipeline in Pharma Collaboration

AI-powered target discovery for a bacterial pathogen with a high medical need where no vaccine is currently available  Evaxion’s proprietary ...

September 19, 2023 | Tuesday | News
Kineta Announces New Research Agreement to Evaluate VISTA Biomarker Expression

The primary objective is to evaluate VISTA as a biomarker to guide patient selection and treatment optimization for VISTA-targeted therapies where no stand...

September 19, 2023 | Tuesday | News
HUTCHMED Completes Patient Enrollment for Tazemetostat Study in Chinese Follicular Lymphoma

The bridging study is a multicenter, open-label, Phase II study to evaluate the efficacy, safety and pharmacokinetics of tazemetostat for the treatment of ...

September 12, 2023 | Tuesday | News
CPHI Barcelona 2023: Forging Collaborations for a Promising Future in the Pharmaceutical Sector

Uniting the Global Supply Chain: CPHI Barcelona serves as a vital platform for unrivalled networks and access to the global supply chain. It provides unpa...

September 08, 2023 | Friday | News
Aziyo Biologics Rebrands as Elutia to Reflect Strategic Focus on Drug Eluting Biomatrices

Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”)  announced a change of the Company’s name to Elutia Inc. The rebranding reflects the ...

September 07, 2023 | Thursday | News
Twist Bioscience and Ono Pharmaceutical Collaborate on Autoimmune Antibodies

“Ono has a strong and proven track record in developing antibody candidates in areas of need, including the development of the anti-PD-1 antibody Opd...

September 01, 2023 | Friday | News
23andMe Granted New FDA Clearance to Report Additional BRCA Variants

510(k) clearance will allow 23andMe to report an additional 41 genetic variants in the BRCA1 and BRCA2 genes that increase risk for breast, ovarian, prosta...

September 01, 2023 | Friday | News
Catalent Announces Governance Enhancements and New Initiatives to Drive Value

Adding Four New Independent Directors Appoints John Greisch as Executive Chair Establishes New Strategic and Operational Review Committee of the Board ...

August 30, 2023 | Wednesday | News
ImmunoGen Teams Up with Takeda to Bring ELAHERE® to Japanese Market

ImmunoGen to Receive $34 Million1 in Upfront and Near-Term Milestone Payments and is Eligible to Receive Potential Regulatory and Commercial Milestone Paym...

August 29, 2023 | Tuesday | News
Twist Bioscience Releases 2023 ESG Report and Quantifies Carbon Footprint of Manufacturing a Single Gene

“We took a big step forward in our ongoing commitment to deliver sustainable solutions to our customers, quantifying the impact of our proprietary ap...

August 23, 2023 | Wednesday | Reports
LEO Pharma Signs Agreement to Acquire Timber Pharmaceuticals

The deal represents a total transaction value of up to $36 million with (i) an initial upfront consideration of $14 million, and (ii) up to an additional $...

August 22, 2023 | Tuesday | News
Study Explores Masimo PVi® for Targeted Liquid Therapy in Elderly Surgical Patients

Researchers found that fluid therapy guided by non-invasive and continuous PVi can reduce cardiopulmonary complications and infusion.   Masimo (NASD...

August 22, 2023 | Tuesday | News
AGC Biologics Partners with Asahi Kasei Pharma Corporation on Clinical Antibody Project

Under the agreement, AGC Biologics will leverage its monoclonal antibody development and manufacturing experience to perform process transfer, process opti...

August 17, 2023 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2023 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close